nmpa_logo

China approves first homegrown HPV vaccine

January 8, 2020
Research and Development, Sales and Marketing China, HPV, NMPA, pharma, vaccines

Female patients in China between the ages of nine and 45 will have access to the country’s first domestically-produced vaccine …

26795071995_1a72be4ca3_b

No link between talc and ovarian cancer, new study reveals

January 8, 2020
Research and Development . Johnson & Johnson, Johnson & Johnson, baby powder, talc, talc powder

Researchers examining data from over 252,000 women have concluded that there is no statistically significant link between the use of …

shutterstock

Apellis therapy outflanks Alexion’s Soliris in head-to-head paroxysmal nocturnal haemoglobinuria

January 8, 2020
Research and Development Alexion, Appelis, pegcetacoplan, pharma, soliris

Apellis Pharmaceuticals has revealed new Phase 3 demonstrating that its targeted C3 inhibitor pegcetacoplan met its primary endpoint and outclassed …

14281921538_bacbef11bc_b

Pharmacies argue that prescribers bear ultimate responsibility for the opioid crisis

January 8, 2020
Research and Development Bernie Sanders, OxyContin, opioid crisis, opioids

Pharmacy chains have argued in federal court that doctors and healthcare practitioners who write prescriptions bear ultimate responsibility for the …

abbottweb

FDA approves alternative approach for Abbot HeartMate 3 heart pump

January 8, 2020
Research and Development Abbott, FDA, Heart Pump, US Pharma, heart disease

The FDA announced today that it has approved a new alternative surgical technique for Abbot’s HeartMate 3 heart pump. The …

rami-levin-picture-3-002

Saniona appoints Rami Levin as President and Chief Executive Officer

January 8, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, rare diseases

Saniona has announced that Rami Levin will take over as the Chief Executive Officer of the company as it seeks …

enrique_conterno

FibroGen names Lilly veteran as new CEO

January 7, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, fibrogen, pharma

Eli Lilly veteran Enrique Conterno has been revealed as the new Chief Executive Officer of FibroGen following the unexpected death …

glenmark

FDA approves Glenmark’s generic version of Novartis’ Exjade tablets for chronic iron overload

January 7, 2020
Manufacturing and Production, Research and Development Glenmark, exjade, generic, pharma

Indian pharma firm Glenmark has announced it has secured approval from the FDA for its oral deferasirox tablets in the …

shutterstock_38078521

Bavencio extends survival at Phase 3 in previously untreated locally advanced or metastatic urothelial carcinoma

January 7, 2020
Manufacturing and Production, Research and Development Bavencio, Merck KGaA, Pfizer, pharma

Bavencio (avelumab), the anti-programmed death ligand-1 (PD-L1) antibody co-developed by Pfizer and Merck KGaA’s biopharma unit EMD Serono, has been …

merckwindow_web

Bittersweet Phase 3 Keytruda data hits one of two goals in extensive stage small cell lung cancer

January 7, 2020
Manufacturing and Production, Research and Development MSD, keytruda

MSD has lifted the curtain on new Phase 3 data on the efficacy of its blockbuster immunotherapy Keytruda, in combination …

teva_copy

Teva to settle bribery lawsuit with $54 million payout

January 7, 2020
Manufacturing and Production, Sales and Marketing Teva, bribery, pharma

Israeli drug firm Teva has agreed to settle an ongoing lawsuit levying allegations of the company’s bribery of doctors, it …

8266471202_63a8f743a9_b_0

Merck, Novartis and Allergan to raise US drug prices, following most of drug industry

January 6, 2020
Manufacturing and Production Allgeran, Big Pharma, Merck, Novartis, drug, drug prices

Following most of the large pharmaceutical companies, Merck, Novartis and Allergan have chosen to raise their drug prices. Novartis is …

ipsen-logo-big

MHRA expands approval of Dysport for symptomatic treatment of focal spasticity of the upper limbs in paediatric cerebral palsy

January 6, 2020
Sales and Marketing Dysport, MHRA, ipsen, pharma

Ipsen has secured an expansion in the UK to the existing label for Dysport (lemborexant), with the Medicines and Healthcare …

5204602349_c87b204860_b

FDA gives a priority review for key heart failure drug Farxiga

January 6, 2020
Sales and Marketing AstraZeneca, Heart Failures, farxiga

The FDA has accepted a New Drug Application (sNDA) and has granted a priority review for AstraZeneca’s drug Farxiga (dapagliflozin) …

smog_descends_on_wuhan_hubei_china

Mysterious viral pneumonia infects dozens in central China, bird flu and SARS ruled out

January 6, 2020
Sales and Marketing Bird Flu, China, Sars, WHO, World Health Organisation, Wuhan, pneumonia

A total of 59 cases of viral pneumonia have been reported in the city of Wuhan, with seven people in …

stock-incyte-01-shutter

Incyte’s drug stumbles at Phase 3 in treatment-naive acute graft-versus-host disease

January 6, 2020
Research and Development, Sales and Marketing Incyte, pharma, trial failure

Drugmaker Incyte has made it known that its selective JAK1 inhibitor therapy itacitinib fell short at Phase 3 in the …

AstraZeneca’s drug Lokelma approved in China

January 6, 2020
Sales and Marketing AstraZeneca, China, FDA, eu commission, kidney failure, potassium

AstraZeneca’s Lokelma has been approved by the National Medical Products Administration in China. This is due to positive results based …

Novo Nordisk to offer US patient’s in immediate need free insulin

January 3, 2020
Medical Communications Novo, Novo Nordisk, Type 1 diabetes, diabetes, insulin, type 2 diabetes

Novo Nordisk said it would offer free, one-time supply of insulin to those in need, amidst rising insulin prices. Novo …

Single cycle of chemo is just as effective as two in treating testicular cancer, study finds

January 3, 2020
Medical Communications Cancer, Men's Cancer, chemo, chemotherapy, testicular cancer

A new study shows that testicular cancer can be successfully treated with less rounds of chemotherapy. The recent study, published …

47028496254_21a33b62df_b

NICE rules against the use of Akcea’s Waylivra in the NHS

January 3, 2020
Medical Communications Akcea, European Commission, FCS, NHS, NICE

NICE has not recommended Akcea’s drug Waylivra (volanesorsen) to be used for the treatment of Familial Chylomicronaemia Syndrome (FCS) in …

The Gateway to Local Adoption Series

Latest content